BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges

by Laetitia Collet, Laetitia Collet, Laetitia Collet, Brunhilde Hanvic, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Olivia Le Saux, Isabelle Ray-Coquard, Isabelle Ray-Coquard
Published 2024-03-01